Concepedia

Karl B. Scheidweiler

KB

73

Publications

4.1K

Citations

42

H-Index

2000

Active since

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

University of Maryland, Baltimore

Bristol-Myers Squibb (United States)

Swedish National Board of Forensic Medicine

Karl B. Scheidweiler is an author at National Institute on Drug Abuse specializing in pharmacology, medicine, and drug analysis.

Top concepts

Publications per year

2000–2018

73

Publications

73

Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay

M R Lee, Karl B. Scheidweiler, Xingxing Diao et al. · Molecular Psychiatry · 2017 · 240 citations · Full text

, , +8

Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake

Matthew N. Newmeyer, Madeleine J. Swortwood, Allan J. Barnes et al. · Clinical Chemistry · 2016 · 174 citations

Phase I and II Cannabinoid Disposition in Blood and Plasma of Occasional and Frequent Smokers Following Controlled Smoked Cannabis

Nathalie A. Desrosiers, Sarah K. Himes, Karl B. Scheidweiler et al. · Clinical Chemistry · 2014 · 149 citations · Full text

Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws

Mateus M. Bergamaschi, Erin L Karschner, Robert S. Goodwin et al. · Clinical Chemistry · 2013 · 148 citations · Full text

Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry

Karl B. Scheidweiler, Michael J. Y. Jarvis, Marilyn A. Huestis · Analytical and Bioanalytical Chemistry · 2014 · 133 citations

, , +15

Rows per page

1–5 of 73